In particular, the expression of CYP2A6 decreased dramatically in patients with macrovascular metastases and severe liver inflammation, suggesting that CYP2A6 is mainly affected by the progression of liver cancer and is involved in the inflammatory microenvironment of HCC. The gene discussed is CYP2A6; the disease is hepatocellular carcinoma.